The potential elevation of intracellular calcium levels and PKC activation may lead to the apparent exocytosis of growth hormone-containing vesicles from pituitary cells
Known Side Effects Reported side effects are generally mild and infrequent: Injection site reactions: temporary redness, mild swelling, or tenderness Nausea: occasionally reported, usually mild and transient Dizziness: rare, typically with first doses Fatigue: some users report temporary tiredness Headache: infrequent, usually resolves quickly These effects typically diminish with continued use and rarely require treatment discontinuation
The T4 group had improved walk time and cardiac function after 6 months.[ref] Animal Studies: Studies on TB4 in animals show: In a mouse model of pulmonary hypertension, treatment with T4 attenuated the blood pressure problem and heart hypertrophy.[ref] Animal studies show T4 helps repair the damage from a heart attack and also improves the vasculature of the heart.[ref][ref] In the liver, Thymosin beta 4 injections prevent liver damage and fibrosis from alcohol.[ref] Animal studies also show that TB4 prevents lung fibrosis by alleviating inflammation.[ref] TB4, plus the enzyme that creates the TB4-frag, was shown in mice to reduce kidney fibrosis and repair kidney health.[ref] What is TB-500: Another form of thymosin beta 4 available as a peptide is called TB-500
First violations typically result in suspensions ranging from one to four years depending on the substance and circumstances
PubChem PubChem entry for SLU-PP-332 (CAS 303760-60-3)
99%, 0,12 0,17 /
